CLOSE X
GO

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
29.91 -0.22(-0.73%) NAV as on 29 Apr 2025
1.73 % 1 M
13.51 % 1 Y
18.45 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.34

As on 31 Mar, 2025
age-icon Age :

5 yrs 9 m

Since 10 07 ,2019
exit_load Exit Load :

1%

aum AUM :

814.95 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.41

Min_Investment Min. Investment :

SIP 100 & Lumpsum 1000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Dhaval Shah

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2025
Others 1.21 %
Equity 98.79 %

TOP HOLDINGS

Sun Pharmaceutical Industries...14.61 %
Cipla Ltd.8.44 %
Torrent Pharmaceuticals Ltd.7.05 %
Apollo Hospitals Enterprise Ltd.6.90 %
Abbott India Ltd.6.14 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs79.07
Hospital & Healthcare Services17.50
Business Support1.46
Chemicals0.76
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)16.1218.2216.3626.4529.39
Net Assets(Rs Crores) (as on 31-Mar-2025) 454.91 515.33 428.44 699.55 814.95
Scheme Returns(%)(Absolute)63.4912.40-10.2661.3810.03
B'mark Returns(%)(Absolute)NANANANANA
Category Rank55/7549/7570/7611/9032/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity29.91-0.22(-0.73%)NAV As on 29 Apr, 202510-Jul-2019Inception Date814.95AUM In Cr.13.51%1Y18.45%3Y19.26%5Y20.76%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.27-0.28(-0.75%)NAV As on 29 Apr, 202513-Jul-2018Inception Date4,914.64AUM In Cr.20.77%1Y24.16%3Y25.01%5Y21.35%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity420.24-2.22(-0.53%)NAV As on 29 Apr, 202514-Jul-1999Inception Date3,610.51AUM In Cr.20.63%1Y23.83%3Y24.41%5Y16.32%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.30-0.28(-0.93%)NAV As on 29 Apr, 202528-Dec-2015Inception Date1,183.65AUM In Cr.15.75%1Y20.26%3Y21.78%5Y12.19%Since Inception
Nippon India Pharma Fund(G)Very HighEquity496.60-3.09(-0.62%)NAV As on 29 Apr, 202505-Jun-2004Inception Date8,080.97AUM In Cr.15.44%1Y20.01%3Y22.50%5Y20.53%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors